Beta Bionics, Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-05-21 meeting.
“Proposal 2. Ratification of Appointment of Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment by the Audit Committee of the Company’s Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, by the following vote: Votes For Votes Against Abstentions 36,011,432 41,527 8,089”
Shareholder Votes
Beta Bionics, Inc. shareholders approved Election of two Class I directors, Sean D. Carney and Christy Jones at the 2026-05-21 meeting.
“Proposal 1. Election of Directors The Company’s stockholders elected two Class I directors, Sean D. Carney and Christy Jones, to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal, by the following vote: Name of Director Votes For Votes Withheld Broker Non-Votes Sean D. Carney 30,659,060 608,992 4,792,996 Christy Jones 25,865,542 5,402,510 4,792,996”
Earnings Releases
Beta Bionics, Inc. updated its the quarter ended March 31, 2026 guidance (raised).
“Beta Bionics, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2026.”
Gerard Michel was appointed as Class III director at Beta Bionics, Inc..
“On March 26, 2025, the Board of Directors (the “Board”) of Beta Bionics, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Gerard Michel as a Class III director of the Company, with a term of office expiring at the 2028 annual meeting of stockholders.”
Governance Changes
Beta Bionics, Inc.: Adopted amended and restated bylaws in connection with the closing of the IPO, effective January 31, 2025 (effective 2025-01-31).
“Effective as of January 31, 2025, the Company adopted the amended and restated bylaws (the “Restated Bylaws”) in connection with the closing of the IPO.”
Governance Changes
Beta Bionics, Inc.: Filed an amended and restated certificate of incorporation in connection with the closing of the IPO, effective January 31, 2025 (effective 2025-01-31).
“In connection with the closing of the initial public offering (“IPO”) of shares of common stock of the Company, on January 31, 2025, the Company filed an amended and restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.